Updates

EpicentRx and Texas Children’s Cancer Center announce the initiation of a Phase 1 clinical trial with RRx-001 for pediatric CNS tumors

02/24/2022 Health Briefs

min. read

Topics

Read

Full media story at www.epicentrx.com

Related Stories

Health Briefs Aug 29, 2025

Surge of new drugs fuels optimism in pediatric oncology

onclive.com
Health Briefs Aug 28, 2025

Health Briefs Aug 28, 2025

Health Briefs Aug 25, 2025

Texas Children’s Cancer and Hematology Center celebrates Awareness Month

texaschildrens.org
Health Briefs Aug 25, 2025

How one program is ensuring cancer survivors have support for the long term

click2houston.com
Health Briefs Aug 05, 2025

Duncan NRI Attends Final Game of the Genuine Cup for Neurodiverse Players

See more results